IhumanInc Capital Surpluse vs Non Current Assets Total Analysis
IH Stock | USD 2.02 0.04 2.02% |
IhumanInc financial indicator trend analysis is infinitely more than just investigating IhumanInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IhumanInc is a good investment. Please check the relationship between IhumanInc Capital Surpluse and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IhumanInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in IhumanInc Stock please use our How to Invest in IhumanInc guide.
Capital Surpluse vs Non Current Assets Total
Capital Surpluse vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IhumanInc Capital Surpluse account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between IhumanInc's Capital Surpluse and Non Current Assets Total is 0.92. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of IhumanInc, assuming nothing else is changed. The correlation between historical values of IhumanInc's Capital Surpluse and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of IhumanInc are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Capital Surpluse i.e., IhumanInc's Capital Surpluse and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Capital Surpluse
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from IhumanInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IhumanInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IhumanInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in IhumanInc Stock please use our How to Invest in IhumanInc guide.As of now, IhumanInc's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 660.6M | 691.2M | 721.3M | 483.8M | Total Revenue | 944.7M | 985.5M | 1.0B | 702.3M |
IhumanInc fundamental ratios Correlations
Click cells to compare fundamentals
IhumanInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
IhumanInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
Other Current Liab | 880K | 107.5M | 124.7M | 151.7M | 148.1M | 112.2M | |
Total Current Liabilities | 182.8M | 399.2M | 482.9M | 561.1M | 490.8M | 410.5M | |
Total Stockholder Equity | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
Property Plant And Equipment Net | 2.5M | 12.9M | 50.5M | 22.0M | 9.8M | 18.0M | |
Current Deferred Revenue | 71.8M | 268.6M | 303.0M | 379.1M | 318.6M | 251.0M | |
Net Debt | (104.9M) | (855.1M) | (821.1M) | (1.0B) | (1.2B) | (1.1B) | |
Retained Earnings | (348.5M) | (386.0M) | (423.0M) | (321.2M) | (140.5M) | (147.5M) | |
Accounts Payable | 10.3M | 21.6M | 30.5M | 24.2M | 22.1M | 22.3M | |
Cash | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
Non Current Assets Total | 5.3M | 25.5M | 85.6M | 79.6M | 68.1M | 48.6M | |
Non Currrent Assets Other | 2.7M | 784K | 7.8M | 6.4M | 8.7M | 4.9M | |
Other Assets | 2.7M | 784K | 7.8M | 6.4M | 7.4M | 4.0M | |
Cash And Short Term Investments | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
Net Receivables | 21.0M | 78.3M | 59.0M | 81.9M | 62.6M | 58.0M | |
Liabilities And Stockholders Equity | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
Non Current Liabilities Total | 82.1M | 5.1M | 9.6M | 2.9M | 1.9M | 1.8M | |
Capital Surpluse | 213.1M | 1.1B | 1.1B | 1.1B | 1.2B | 751.9M | |
Inventory | 20.7M | 16.9M | 28.1M | 19.1M | 16.5M | 17.4M | |
Other Current Assets | 574K | 64.6M | 72.9M | 102.8M | 8.1M | 7.7M | |
Other Stockholder Equity | 333.9M | 1.1B | 1.1B | 1.1B | 1.1B | 844.0M | |
Total Liab | 182.8M | 404.3M | 492.5M | 563.9M | 492.7M | 414.1M | |
Net Invested Capital | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
Total Current Assets | 163.1M | 1.0B | 1.0B | 1.3B | 1.4B | 897.1M | |
Accumulated Other Comprehensive Income | 0.0 | (21.9M) | (34.7M) | 18.5M | 26.1M | 27.4M | |
Cash And Equivalents | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 633.2M | |
Net Working Capital | (19.7M) | 622.2M | 532.3M | 692.7M | 891.7M | 486.6M | |
Short Term Debt | 99.8M | 1.5M | 24.7M | 6.1M | 1.9M | 1.8M | |
Intangible Assets | 103K | 11.8M | 27.3M | 24.9M | 23.2M | 16.0M | |
Property Plant Equipment | 2.5M | 12.9M | 50.5M | 22.0M | 25.3M | 19.5M |
Currently Active Assets on Macroaxis
When determining whether IhumanInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IhumanInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ihumaninc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ihumaninc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IhumanInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in IhumanInc Stock please use our How to Invest in IhumanInc guide.Note that the IhumanInc information on this page should be used as a complementary analysis to other IhumanInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for IhumanInc Stock analysis
When running IhumanInc's price analysis, check to measure IhumanInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IhumanInc is operating at the current time. Most of IhumanInc's value examination focuses on studying past and present price action to predict the probability of IhumanInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IhumanInc's price. Additionally, you may evaluate how the addition of IhumanInc to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is IhumanInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IhumanInc. If investors know IhumanInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IhumanInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Earnings Share 0.46 | Revenue Per Share 19.279 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0718 |
The market value of IhumanInc is measured differently than its book value, which is the value of IhumanInc that is recorded on the company's balance sheet. Investors also form their own opinion of IhumanInc's value that differs from its market value or its book value, called intrinsic value, which is IhumanInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IhumanInc's market value can be influenced by many factors that don't directly affect IhumanInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IhumanInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if IhumanInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IhumanInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.